Last reviewed · How we verify
Apiquel (AMINOREX)
Aminorex (Apiquel) is a marketed weight loss drug that stimulates the release of neurotransmitters to regulate appetite and metabolism. Its key strength lies in its unique mechanism of action, which differentiates it from other weight loss treatments. The primary risk is the patent expiry in 2028, which could lead to increased competition from generics.
At a glance
| Generic name | AMINOREX |
|---|---|
| Drug class | aminorex |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Weight loss
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Apiquel CI brief — competitive landscape report
- Apiquel updates RSS · CI watch RSS